AstraZeneca cuts 600 US jobs amid $1.5B cost-saving overhaul – Bloomberg
Summary
Pharmaceutical giant AstraZeneca is eliminating six hundred positions across its United States operations as part of a major financial restructuring program. The workforce reduction is tied to a broader cost-saving initiative valued at one and a half billion dollars.
Source: Read the full story at Stock Market News
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.